about
Novel Investigations of Flavonoids as Chemopreventive Agents for Hepatocellular CarcinomaThe mutational landscape of hepatocellular carcinomaThe Cytokinome Profile in Patients with Hepatocellular Carcinoma and Type 2 DiabetesTumor-associated autoantibodies are useful biomarkers in immunodiagnosis of α-fetoprotein-negative hepatocellular carcinomaAssociation between MDM2 rs769412 and rs937283 polymorphisms with alcohol drinking and laryngeal carcinoma riskBiphasic and Stage-Associated Expression of CPEB4 in Hepatocellular Carcinoma.Expression of P53 and HSP70 in Chronic Hepatitis, Liver Cirrhosis, and Early and Advanced Hepatocellular Carcinoma Tissues and Their Diagnostic Value in Hepatocellular Carcinoma: An Immunohistochemical Study.Association of RNF43 with cell cycle proteins involved in p53 pathway.HBP1-mediated Regulation of p21 Protein through the Mdm2/p53 and TCF4/EZH2 Pathways and Its Impact on Cell Senescence and Tumorigenesis.Armored long non-coding RNA MEG3 targeting EGFR based on recombinant MS2 bacteriophage virus-like particles against hepatocellular carcinoma.Downregulation of cyclin D1 sensitizes cancer cells to MDM2 antagonist Nutlin-3p53, a potential predictor of Helicobacter pylori infection-associated gastric carcinogenesis?Dynamics of p53: A Master Decider of Cell Fate.MicroRNA-98 acts as a tumor suppressor in hepatocellular carcinoma via targeting SALL4Novel MDM2 inhibitor SAR405838 (MI-773) induces p53-mediated apoptosis in neuroblastoma.TRIM11, a direct target of miR-24-3p, promotes cell proliferation and inhibits apoptosis in colon cancer.The FHL2 regulation in the transcriptional circuitry of human cancers.Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.H2.0-like homeobox 1 acts as a tumor suppressor in hepatocellular carcinoma.Reviving the guardian of the genome: Small molecule activators of p53.Activation of PERK-Nrf2 oncogenic signaling promotes Mdm2-mediated Rb degradation in persistently infected HCV culture.NORE1A Regulates MDM2 Via β-TrCP.Emerging roles of FGF signaling in hepatocellular carcinoma.CDKN3 expression is negatively associated with pathological tumor stage and CDKN3 inhibition promotes cell survival in hepatocellular carcinoma.Histone deacetylase inhibitor sodium butyrate suppresses proliferation and promotes apoptosis in osteosarcoma cells by regulation of the MDM2-p53 signaling.Tetrahydrocurcumin is more effective than curcumin in inducing the apoptosis of H22 cells via regulation of a mitochondrial apoptosis pathway in ascites tumor-bearing mice.Up-regulation of small nucleolar RNA 78 is correlated with aggressive phenotype and poor prognosis of hepatocellular carcinoma.Stress Hormone Cortisol Enhances Bcl2 Like-12 Expression to Inhibit p53 in Hepatocellular Carcinoma Cells.SIX1 and DACH1 influence the proliferation and apoptosis of hepatocellular carcinoma through regulating p53.Inhibition of Mdmx (Mdm4) in vivo induces anti-obesity effects.Interferon-alpha-induced hepatitis C virus clearance restores p53 tumor suppressor more than direct-acting antivirals.TPX2 Level Correlates with Hepatocellular Carcinoma Cell Proliferation, Apoptosis, and EMT.Screening therapeutic targets of ribavirin in hepatocellular carcinoma.Host and Viral Genetic Variation in HBV-Related Hepatocellular CarcinomaRBM38 plays a tumor-suppressor role via stabilizing the p53-mdm2 loop function in hepatocellular carcinoma
P2860
Q26767372-3DB84E80-70DC-49BD-9F88-11D3683D5410Q26777478-AB24C97C-F231-43D6-8DAC-F3A703EA201DQ28546913-304C59C2-6EDE-4963-9FD0-BA67D952548AQ33719973-1E7AB45F-B3BD-4C63-8D0B-73976445DF74Q35919512-90E25135-4E3D-4E31-957F-C95B77DBAA69Q36012026-2967574D-BB85-4556-8023-E215A48ADD5FQ36211990-7D4F06AC-BB8E-431E-B51C-1AC986127C01Q36464762-943E7475-57CD-480D-85F8-645473924AECQ37066459-576CC3DC-AD07-4FC3-84D3-97AA123D4A56Q37269190-FC6D5A00-7C21-49F4-9F8A-EA53C8C3C658Q37362736-F242CF56-A68F-4A09-BB6B-AFF9085A32C2Q37662406-8CF0EC29-9369-4B75-B9B1-B30113472D65Q37676245-E6482506-BD77-4D8A-83B3-5CD9B0A51D1EQ37687523-277CF0F1-077B-45F4-9EC6-D5C6121188FFQ37696208-E0FB366F-DA03-4A5C-8F12-BFFC8DB05BB0Q37699330-38CD75B5-7939-463E-896E-B72BDA6F1CA8Q38554494-C56DD6BA-92EC-4FB4-8F22-5A1DBE2CF4B6Q38727481-AD22A5AF-131D-4AC6-A3C3-10D5A4DD0DA9Q38814845-1A451EEB-3C5D-4958-8E0C-D4A7ED26121FQ39205536-444BBE62-222E-410D-B90E-DB7B76491D7EQ40072826-75A114DB-1C16-48FC-85CA-DDC7B4BAA6ECQ40681916-435718D7-A946-47D1-8815-0705A62F6892Q41876265-23EC6A2E-239F-4DDE-B8D0-5628CA0C47F9Q42058767-7E64DDCC-07A1-45C6-9EA3-29C25CD40020Q42427815-94347C69-BD51-4F2F-A256-DA4F2460772AQ46327354-C793F359-D1BA-42A4-A35B-03316EB1E10AQ46473475-AEA5C6BE-4BF4-4B13-8921-6E74525E7D01Q47635874-CFF0FFDA-EAEA-4FF9-9062-8C97A3C27D75Q50047509-7D537989-A0FE-466A-9D9F-B0D6B870D78AQ50421763-BC674817-DEA9-4498-8189-831A86C62A88Q52733603-1FC95919-69D7-401B-8C93-CDAD3B9D7916Q52940060-CF53EA7C-FCD1-4E9D-98BA-127734F99F13Q55331757-050C3900-80BE-40FA-A8B2-E9BACDF978D5Q56976434-8403AD89-83AB-4699-A235-ACEC6AA555C1Q58768940-57D26C30-5CD4-44ED-907E-682D85F5F9BD
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
MDM2-p53 pathway in hepatocellular carcinoma.
@ast
MDM2-p53 pathway in hepatocellular carcinoma.
@en
type
label
MDM2-p53 pathway in hepatocellular carcinoma.
@ast
MDM2-p53 pathway in hepatocellular carcinoma.
@en
prefLabel
MDM2-p53 pathway in hepatocellular carcinoma.
@ast
MDM2-p53 pathway in hepatocellular carcinoma.
@en
P2093
P2860
P1433
P1476
MDM2-p53 pathway in hepatocellular carcinoma.
@en
P2093
Jiahong Dong
Yanping Zhang
P2860
P304
P356
10.1158/0008-5472.CAN-14-1446
P407
P577
2014-12-04T00:00:00Z